Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

Delayed Quote. Delayed London Stock Exchange - 05/22 11:35:03 am
22.75 GBp   +4.00%
03/30 PROTEOME SCIENC : Block Admission Report
03/18 PROTEOME SCIENC : presenting on blood biomarkers and tau targeted th..
03/18 PROTEOME SCIENC : PS presenting on blood biomarkers & tau targeted t..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
23.125(c) 23.375(c) 22(c) 21.875(c) 22.75(c) Last
39 176 15 021 203 400 174 296 59 000 Volume
+1.65% +1.08% -5.88% -0.57% +4.00% Change
More quotes
Financials ( GBP)
Sales 2014 1,68 M
EBIT 2014 -3,78 M
Net income 2014 -3,52 M
Debt 2014 5,90 M
Yield 2014 -
Sales 2015 2,12 M
EBIT 2015 -3,70 M
Net income 2015 -3,48 M
Debt 2015 8,90 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 32,6x
EV / Sales 2015 27,2x
Capitalization 48,7 M
More Financials
Company
Proteome Sciences Plc is a protein biomarker discovery service company, which specializes in proteomics and peptidomics services and applications, and a best-in-class mass spectrometry protein analysis capability.It offers sensitivity, proprietary technologies for protein and peptide biomarker... 
More about the company
Latest news on PROTEOME SCIENCES PLC
03/30 PROTEOME SCIENCES : Block Admission Report
03/18 PROTEOME SCIENCES : presenting on blood biomarkers and tau targeted therapies at..
03/18 PROTEOME SCIENCES : PS presenting on blood biomarkers & tau targeted therapies a..
03/17 PROTEOME SCIENCES : Presenting On Blood Biomarkers And TAU Targeted Therapies At..
03/09 PROTEOME SCIENCES : Sees Good Start To 2015 On Contract Signings
03/09 PROTEOME SCIENCES : Trading Update
02/11 PROTEOME SCIENCES : extends its reach through collaboration with MedBiomix Partn..
2014 PROTEOME SCIENCES : Mr. James Malthouse has retired as a director of the Company..
More news
Sector news : Bio Therapeutic Drugs
05/24 QUINTILES TRANSNATIONAL : Launches New Solution to Meet Needs of Asia-Pacific Em..
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions